Chartwell Investment Partners, LLC Axonics, Inc. Transaction History

Chartwell Investment Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$52.6 - $67.34 $648,189 - $829,830	-12,323 Reduced 36.57%	21,377 $1.17 Million
Q4 2022 Feb 15, 2023	SELL	$59.56 - $76.6 $1.06 Million - $1.36 Million	-17,774 Reduced 34.53%	33,700 $2.11 Million
Q3 2022 Oct 27, 2022	BUY	$57.96 - $78.12 $104,443 - $140,772	1,802 Added 3.63%	51,474 $3.63 Million
Q2 2022 Aug 01, 2022	BUY	$39.5 - $64.42 $49,059 - $80,009	1,242 Added 2.56%	49,672 $2.82 Million
Q1 2022 Apr 26, 2022	BUY	$43.74 - $62.76 $88,660 - $127,214	2,027 Added 4.37%	48,430 $3.03 Million
Q4 2021 Feb 15, 2022	SELL	$50.01 - $73.35 $41,358 - $60,660	-827 Reduced 1.75%	46,403 $2.6 Million
Q3 2021 Nov 16, 2021	SELL	$59.21 - $78.66 $843,564 - $1.12 Million	-14,247 Reduced 23.17%	47,230 $3.07 Million
Q2 2021 Jul 19, 2021	BUY	$51.39 - $66.9 $1.42 Million - $1.85 Million	27,660 Added 81.79%	61,477 $3.9 Million
Q1 2021 May 03, 2021	BUY	$49.14 - $59.89 $1.66 Million - $2.03 Million	33,817 New	33,817 $2.03 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.